| Product Code: ETC8449720 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Myanmar Cyclooxygenase 2 Inhibitor Market Overview |
3.1 Myanmar Country Macro Economic Indicators |
3.2 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, 2021 & 2031F |
3.3 Myanmar Cyclooxygenase 2 Inhibitor Market - Industry Life Cycle |
3.4 Myanmar Cyclooxygenase 2 Inhibitor Market - Porter's Five Forces |
3.5 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.7 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Myanmar Cyclooxygenase 2 Inhibitor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases that require cyclooxygenase 2 inhibitors for management |
4.2.2 Growing geriatric population in Myanmar with higher incidences of osteoarthritis and other inflammatory conditions |
4.2.3 Rising healthcare expenditure and improving access to advanced pharmaceuticals in the country |
4.3 Market Restraints |
4.3.1 Limited awareness among healthcare professionals and patients about the benefits of cyclooxygenase 2 inhibitors |
4.3.2 Stringent regulations and slow approval processes for new pharmaceutical products in Myanmar |
4.3.3 Presence of alternative pain management therapies and traditional medicine practices that compete with cyclooxygenase 2 inhibitors |
5 Myanmar Cyclooxygenase 2 Inhibitor Market Trends |
6 Myanmar Cyclooxygenase 2 Inhibitor Market, By Types |
6.1 Myanmar Cyclooxygenase 2 Inhibitor Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Celecoxib, 2021- 2031F |
6.1.4 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Rofecoxib, 2021- 2031F |
6.1.5 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Valdecoxib, 2021- 2031F |
6.1.6 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Amlodipine, 2021- 2031F |
6.1.7 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Myanmar Cyclooxygenase 2 Inhibitor Market, By Types |
6.2.1 Overview and Analysis |
6.2.2 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Selective cox 2 inhibitor, 2021- 2031F |
6.2.3 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Non-selective cox 2 inhibitor, 2021- 2031F |
6.3 Myanmar Cyclooxygenase 2 Inhibitor Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Osteoarthritis, 2021- 2031F |
6.3.3 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Rheumatoid arthritis, 2021- 2031F |
6.3.4 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Myanmar Cyclooxygenase 2 Inhibitor Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Myanmar Cyclooxygenase 2 Inhibitor Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Myanmar Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
7 Myanmar Cyclooxygenase 2 Inhibitor Market Import-Export Trade Statistics |
7.1 Myanmar Cyclooxygenase 2 Inhibitor Market Export to Major Countries |
7.2 Myanmar Cyclooxygenase 2 Inhibitor Market Imports from Major Countries |
8 Myanmar Cyclooxygenase 2 Inhibitor Market Key Performance Indicators |
8.1 Average prescription rate of cyclooxygenase 2 inhibitors by healthcare providers |
8.2 Patient adherence rate to prescribed cyclooxygenase 2 inhibitor treatment regimens |
8.3 Number of ongoing clinical trials and research studies focused on cyclooxygenase 2 inhibitors in Myanmar |
9 Myanmar Cyclooxygenase 2 Inhibitor Market - Opportunity Assessment |
9.1 Myanmar Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Myanmar Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Types, 2021 & 2031F |
9.3 Myanmar Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Myanmar Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Myanmar Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Myanmar Cyclooxygenase 2 Inhibitor Market - Competitive Landscape |
10.1 Myanmar Cyclooxygenase 2 Inhibitor Market Revenue Share, By Companies, 2024 |
10.2 Myanmar Cyclooxygenase 2 Inhibitor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here